{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:25:10Z","timestamp":1787505910395,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejca.2024.114294","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:52:38Z","timestamp":1725695558000},"page":"114294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"210","author":[{"given":"Bijuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianji","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouwei","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2024.114294_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.ejca.2024.114294_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021"},{"key":"10.1016\/j.ejca.2024.114294_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","article-title":"Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience","volume":"61","author":"Lee","year":"2005","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"key":"10.1016\/j.ejca.2024.114294_bib4","article-title":"A comparison between the sixth and seventh editions of the UICC\/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2024.114294_bib5","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.30198","article-title":"Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy","volume":"122","author":"Pan","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2024.114294_bib6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/annonc\/mdz231","article-title":"Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China","volume":"30","author":"Ji","year":"2019","journal-title":"Ann Oncol: J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejca.2024.114294_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2023.3010","article-title":"Methods, detection rates, and survival outcomes of screening for head and neck cancers: a systematic review","author":"Sykes","year":"2023","journal-title":"JAMA Otolaryngol-- Head neck Surg"},{"key":"10.1016\/j.ejca.2024.114294_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ijc.2910360505","article-title":"Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA\/VCA antibody-positive persons in Wuzhou City, China","volume":"36","author":"Zeng","year":"1985","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2024.114294_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/kws404","article-title":"Two epstein-barr virus\u2013related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China","volume":"177","author":"Liu","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2024.114294_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma epstein-barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2024.114294_bib11","article-title":"Cancers screening in an asymptomatic population by using multiple tumour markers","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2024.114294_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma epstein\u2013barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2024.114294_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2301496","article-title":"Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer","volume":"389","author":"Li","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2024.114294_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ebiom.2017.03.038","article-title":"Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma","volume":"18","author":"Ye","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejca.2024.114294_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12885-016-2283-4","article-title":"Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma","volume":"16","author":"Tan","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2024.114294_bib16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.imbio.2016.05.008","article-title":"Usefulness of IGF-1 serum levels as diagnostic marker of nasopharyngeal carcinoma","volume":"221","author":"M'Hamdi","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejca.2024.114294_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cca.2017.12.023","article-title":"AGR2 diagnostic value in nasopharyngeal carcinoma prognosis","volume":"484","author":"Li","year":"2018","journal-title":"Clin Chim Acta; Int J Clin Chem"},{"key":"10.1016\/j.ejca.2024.114294_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12014-017-9141-5","article-title":"Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma","volume":"14","author":"Lin","year":"2017","journal-title":"Clin Proteom"},{"key":"10.1016\/j.ejca.2024.114294_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1804184115","article-title":"Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma","volume":"115","author":"Lam","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2024.114294_bib20","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41467-022-29570-4","article-title":"A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening","volume":"13","author":"He","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2024.114294_bib21","doi-asserted-by":"crossref","first-page":"E5503","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2024.114294_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2024.114294_bib23","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1200\/JCO.2015.60.7846","article-title":"Nasopharyngeal Cancer: molecular landscape","volume":"33","author":"Bruce","year":"2015","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114294_bib24","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1038\/s41467-020-20001-w","article-title":"A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation","volume":"11","author":"Cui","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2024.114294_bib25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Sci (N Y, NY)"},{"key":"10.1016\/j.ejca.2024.114294_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/nchem.2064","article-title":"5-Hydroxymethylcytosine is a predominantly stable DNA modification","volume":"6","author":"Bachman","year":"2014","journal-title":"Nat Chem"},{"key":"10.1016\/j.ejca.2024.114294_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ncb3296","article-title":"De novo DNA methylation drives 5hmC accumulation in mouse zygotes","volume":"18","author":"Amouroux","year":"2016","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejca.2024.114294_bib28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/cr.2017.121","article-title":"5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.ejca.2024.114294_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13148-020-0810-2","article-title":"5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease","volume":"12","author":"Dong","year":"2020","journal-title":"Clin epigenetics"},{"key":"10.1016\/j.ejca.2024.114294_bib30","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/bloodadvances.2019000175","article-title":"Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma","volume":"3","author":"Chiu","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.ejca.2024.114294_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41422-018-0014-x","article-title":"Circulating tumor DNA 5-hydroxymethylcytosine as a novel diagnostic biomarker for esophageal cancer","volume":"28","author":"Tian","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.ejca.2024.114294_bib32","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","article-title":"Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma","volume":"68","author":"Cai","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2024.114294_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt.1732","article-title":"Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine","volume":"29","author":"Song","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ejca.2024.114294_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","article-title":"Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer","volume":"559","author":"Wu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2024.114294_bib35","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA: a Cancer J Clin"},{"key":"10.1016\/j.ejca.2024.114294_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-022-02648-4","article-title":"Exaggerated false positives by popular differential expression methods when analyzing human population samples","volume":"23","author":"Li","year":"2022","journal-title":"Genome Biol"},{"key":"10.1016\/j.ejca.2024.114294_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.oraloncology.2007.10.003","article-title":"Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma","volume":"44","author":"Chang","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2024.114294_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mhn.2000.108201","article-title":"Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma","volume":"123","author":"Low","year":"2000","journal-title":"Otolaryngol-Head Neck Surg: J Am Acad Otolaryngol-Head Neck Surg"},{"key":"10.1016\/j.ejca.2024.114294_bib39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cac2.12100","article-title":"Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun (Lond, Engl)"},{"key":"10.1016\/j.ejca.2024.114294_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163609","article-title":"Potential Interest in Circulating miR-BART17-5p As a Post-Treatment Biomarker for Prediction of Recurrence in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma","volume":"11","author":"Hirai","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2024.114294_bib41","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2024.114294_bib42","first-page":"E1666","article-title":"Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: plasma versus urine","volume":"38","author":"Sengar","year":"2016","journal-title":"Head neck"},{"key":"10.1016\/j.ejca.2024.114294_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/gtmb.2011.0012","article-title":"Detection of Epstein-Barr virus DNA in serum or plasma for nasopharyngeal cancer: a meta-analysis","volume":"15","author":"Liu","year":"2011","journal-title":"Genet Test Mol Biomark"},{"key":"10.1016\/j.ejca.2024.114294_bib44","first-page":"885","article-title":"A meta-analysis on the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma","volume":"29","author":"Song","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.ejca.2024.114294_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx007","article-title":"Current state of PCR-based epstein-barr virus DNA testing for nasopharyngeal cancer","volume":"109","author":"Kim","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2024.114294_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-6143.2008.02514.x","article-title":"Interlaboratory comparison of epstein-barr virus viral load assays","volume":"9","author":"Preiksaitis","year":"2009","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2024.114294_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-biochem-060713-035513","article-title":"Mechanism and function of oxidative reversal of DNA and RNA methylation","volume":"83","author":"Shen","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ejca.2024.114294_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cancergen.2015.02.009","article-title":"5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy","volume":"208","author":"Vasanthakumar","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.ejca.2024.114294_bib49","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.cell.2012.11.022","article-title":"MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system","volume":"151","author":"Mell\u00e9n","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2024.114294_bib50","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/gb-2012-13-10-r93","article-title":"Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome","volume":"13","author":"Thomson","year":"2012","journal-title":"Genome Biol"},{"key":"10.1016\/j.ejca.2024.114294_bib51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nn.3976","article-title":"Role of Tet1 and 5-hydroxymethylcytosine in cocaine action","volume":"18","author":"Feng","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ejca.2024.114294_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","article-title":"The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain","volume":"324","author":"Kriaucionis","year":"2009","journal-title":"Sci (N Y, NY)"},{"key":"10.1016\/j.ejca.2024.114294_bib53","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2024.114294_bib54","first-page":"12","article-title":"Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy","volume":"39","author":"Zeng","year":"2019","journal-title":"Cancer Commun (Lond, Engl)"},{"key":"10.1016\/j.ejca.2024.114294_bib55","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1111\/jcmm.14252","article-title":"5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients","volume":"23","author":"Gao","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ejca.2024.114294_bib56","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"36","author":"Merker","year":"2018","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114294_bib57","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.7150\/thno.21389","article-title":"Decrease in lymphoid specific helicase and 5-hydroxymethylcytosine is associated with metastasis and genome instability","volume":"7","author":"Jia","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ejca.2024.114294_bib58","doi-asserted-by":"crossref","first-page":"E7257","DOI":"10.1073\/pnas.1513432112","article-title":"5-hydroxymethylation of the EBV genome regulates the latent to lytic switch","volume":"112","author":"Wille","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2024.114294_bib59","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","article-title":"Evaluation of cell-free DNA approaches for multi-cancer early detection","volume":"40","author":"Jamshidi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2024.114294_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102856","article-title":"Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)","volume":"145","author":"Gerratana","year":"2020","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.ejca.2024.114294_bib61","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41596-019-0202-2","article-title":"Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA","volume":"14","author":"Shen","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ejca.2024.114294_bib62","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hed.20066","article-title":"Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study","volume":"26","author":"Wei","year":"2004","journal-title":"Head neck"},{"key":"10.1016\/j.ejca.2024.114294_bib63","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1200\/JCO.22.01979","article-title":"Performance and operational feasibility of epstein-barr virus-based screening for detection of nasopharyngeal carcinoma: direct comparison of two alternative approaches","volume":"41","author":"Lou","year":"2023","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114294_bib64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.32236","article-title":"Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma","volume":"76","author":"Tian","year":"2022","journal-title":"Hepatol (Baltim, Md)"},{"key":"10.1016\/j.ejca.2024.114294_bib65","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1111\/cas.14970","article-title":"Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma","volume":"112","author":"Yoshimachi","year":"2021","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.ejca.2024.114294_bib66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0022034519860828","article-title":"Ral GTPase activation by downregulation of RalGAP enhances oral squamous cell carcinoma progression","volume":"98","author":"Gao","year":"2019","journal-title":"J Dent Res"},{"key":"10.1016\/j.ejca.2024.114294_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1046044","article-title":"Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejca.2024.114294_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5582\/bst.8.101","article-title":"Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells","volume":"8","author":"Au","year":"2014","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ejca.2024.114294_bib69","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1541-7786.MCR-19-1120","article-title":"Targeting Opsin4\/Melanopsin with a Novel Small Molecule Suppresses PKC\/RAF\/MEK\/ERK Signaling and Inhibits Lung Adenocarcinoma Progression","volume":"18","author":"Wang","year":"2020","journal-title":"Mol Cancer Res: MCR"},{"key":"10.1016\/j.ejca.2024.114294_bib70","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.urolonc.2020.02.010","article-title":"Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma","volume":"38","author":"Han","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ejca.2024.114294_bib71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ijc.25638","article-title":"G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer","volume":"128","author":"Tang","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2024.114294_bib72","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/bjc.2012.409","article-title":"Gut microbiota-derived propionate reduces cancer cell proliferation in the liver","volume":"107","author":"Bindels","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2024.114294_bib73","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/cdd.2010.117","article-title":"Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death","volume":"18","author":"Tang","year":"2011","journal-title":"Cell death Differ"},{"key":"10.1016\/j.ejca.2024.114294_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186334","article-title":"Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells","volume":"12","author":"Thirunavukkarasan","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2024.114294_bib75","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2024.114294_bib76","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","article-title":"The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer","volume":"13","author":"Mattox","year":"2023","journal-title":"Cancer Discov"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492400950X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492400950X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:52:15Z","timestamp":1727106735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492400950X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":76,"alternative-id":["S095980492400950X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114294","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"114294"}}